BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17592990)

  • 1. Chronic obstructive pulmonary disease: thinking outside the opioid box.
    Liao S; Arnold RM
    J Palliat Med; 2007 Jun; 10(3):781-2. PubMed ID: 17592990
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
    Varkey B
    Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized morphine for terminal dyspnea.
    Westphal CG; Campbell ML
    Am J Nurs; 2002 May; Suppl():11-5. PubMed ID: 12006868
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Vozoris NT
    Am J Respir Crit Care Med; 2021 Jan; 203(2):266-267. PubMed ID: 33022187
    [No Abstract]   [Full Text] [Related]  

  • 5. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
    Horton R; Rocker G; Currow D
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioids, Chronic Obstructive Pulmonary Disease, and Hyperbole.
    Vozoris NT
    J Palliat Med; 2018 Jun; 21(6):745. PubMed ID: 29889015
    [No Abstract]   [Full Text] [Related]  

  • 8. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized morphine for the relief of dyspnea.
    Mabe SR; Connelly JF
    Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing dyspnea in advanced chronic obstructive pulmonary disease: balancing all the evidence.
    Mularski RA; Rocker G
    Ann Am Thorac Soc; 2015 Jul; 12(7):978-80. PubMed ID: 26203609
    [No Abstract]   [Full Text] [Related]  

  • 11. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial.
    Ahmadi Z; Sandberg J; Shannon-Honson A; Vandersman Z; Currow DC; Ekström M
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30002106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
    Vozoris NT
    Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The New "Opioid Crisis": Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea.
    Rocker G; Bourbeau J; Downar J
    J Palliat Med; 2018 Feb; 21(2):120-122. PubMed ID: 29393775
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphine for management of refractory dyspnoea: opiates should be used with caution.
    Berrill JW; Linnasne SJ
    BMJ; 2003 Nov; 327(7426):1288; author reply 1288-9. PubMed ID: 14644985
    [No Abstract]   [Full Text] [Related]  

  • 15. End-of-life care in patients with chronic obstructive pulmonary disease.
    Steel A; Goldring J
    Br J Hosp Med (Lond); 2015 Jan; 76(1):C10-3. PubMed ID: 25585191
    [No Abstract]   [Full Text] [Related]  

  • 16. Gaps in Opioid Prescription for Severe Breathlessness in Hospitalized Patients With Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease.
    Chen X; Treanor D; Le B; Smallwood N
    J Pain Symptom Manage; 2020 Sep; 60(3):e36-e39. PubMed ID: 32446973
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series.
    Gauna AA; Kang SK; Triano ML; Swatko ER; Vanston VJ
    J Palliat Med; 2008 May; 11(4):643-8. PubMed ID: 18454622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
    Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
    Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-induced neurotoxicity.
    Gallagher R
    Can Fam Physician; 2007 Mar; 53(3):426-7. PubMed ID: 17872676
    [No Abstract]   [Full Text] [Related]  

  • 20. The need to address increasing opioid use in elderly COPD patients.
    Vozoris NT; O'Donnell DE
    Expert Rev Respir Med; 2016; 10(3):245-8. PubMed ID: 26783198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.